Alere

Waltham, United States Founded: 1991 • Age: 35 yrs Listed Acquired By Abbott
Developer of small rapid diagnostic devices for infectious diseases

About Alere

Alere is a publicly listed company based in Waltham (United States) founded in 1991 by Ron Zwanziger, and was acquired by Abbott in February 2016. Developer of small rapid diagnostic devices for infectious diseases. Alere has raised $616.22 million across 26 funding rounds from investors including Abbott, UBS and Merrill Lynch. The company has 7,011 employees. Alere has completed 11 acquisitions, including Alere Wellbeing, Arriva Medical and Biosite. Alere offers products and services including i-STAT, Afinion 2, and Cholestech LDX Analyzer. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is ALERE INC. Its competitors include Nuna and Apollo Intelligence; 1 of its 2 listed competitors has raised funding.

Company details

Founded in 1991 and headquartered in Waltham, United States, Alere operates in the diagnostics sector. Small rapid diagnostic devices are developed for infectious diseases, with additional focus on cardiology, oncology, drugs of abuse, and womens health. Products and services include over-the-counter tests, lab-based diagnostics, and integrated home monitoring solutions, serving various health management needs globally.

  • Headquarters Waltham, United States
  • Employees 7,011
  • Founders Ron Zwanziger
  • Stage Public
  • Sectors
    Healthcare
  • Website alere.com
  • Social LinkedIn
  • Acquired by Abbott (Feb 2016)
  • Legal Name Alere Inc.
Key Metrics
  • Total Equity Funding
    $616.22M (USD)

    in 26 rounds

  • Latest Funding Round
    $425M (USD), Debt – Conventional

    May 2013

  • Investors
    Abbott

    & 13 more

  • Employee Count
    7,011
  • Investments & Acquisitions
  • Acquired by
    Abbott

    & 1 more

    (Feb 2016)

Products & Services of Alere

Alere offers a comprehensive portfolio of products and services, including i-STAT, Afinion 2, and Cholestech LDX Analyzer.

i-STAT
Diagnostic Analyzer

Portable device for rapid blood and chemistry testing

Afinion 2
Rapid Test System

Analyzer for near-patient biomarker and CRP testing

Cholestech LDX Analyzer
Lipid Profile Device

Tool for quick glucose and lipid testing in five minutes

Funding Insights of Alere

Alere has successfully raised a total of $616.22M across 26 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $425 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $616.22M
  • Total Rounds 26
  • Last Round Debt – Conventional β€” $425M
  • Investors Count 13

Latest 10 of 26 funding rounds of Alere with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2013$425MDebt – Conventional––
–
Feb 2013$21.6MGrant––
Feb 2013$20.6MDebt – Conventional––
Dec 2012$450MDebt – Conventional––
–
Aug 2011Series D–Vitapath Health
–
Oct 2010$400MDebt – Conventional––
–
Oct 2009$100MDebt – Conventional––
–
Jan 2008$8.29MSeries D––
–
Jun 2007Series D–TA
–
May 2007$150MSeries D––
–
Valuation history

14 investors in total: 14 institutional.

Investors in Alere

Alere has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Abbott, UBS and Merrill Lynch.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Multiple sectors are invested in by private equity firm TA.
ta.comBoston, United States
Private equity firm focused on multiple sectors
1982yfmep.comLeeds, United Kingdom
US healthcare companies are invested in stage-agnostically by Cutlass Capital.
cutlasscapital.comBoston, United States
A biotechnology venture capital firm investing in innovative science.
srone.com
Life sciences-focused venture capital firm
1999flagshippioneering.comCambridge, United States
Growth in technology companies is supported through venture capital.
ivp.comMenlo Park, United States
nvven.com
Venture debt is provided globally across multiple sectors.
1980westerntech.comPortola Valley, United States
Charitable foundation investments on poverty reduction and healthcare
2000gatesfoundation.orgSeattle, United States
Serves as a brand offering high-quality nutritional supplements.
2011vitapathhealth.comUnited States
Premium access

Investor details for Alere

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Alere

1 people are tracked at Alere (1 in leadership); the tracked headcount is 7,011.

NameRoleGroup
Ron Zwanziger
FounderLeadership
Premium access

Complete people profiles for Alere

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Alere

Alere has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Alere Wellbeing, Arriva Medical and Biosite.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Diagnostic test kits for life-threatening diseases are supplied.
biosite.comSan Diego, United States1988Aug 2013$1.8B
Developer of diagnostic tests to diagnose diseases such as Malaria, Dengue, HIV and Syphilis at earlier stages
standardia.comSuwon-si, South Korea1999Feb 2013$166M
Healthcare services are provided nationwide by NationsHealth since 2002.
nationshealth.comSunrise, United States2002Dec 2012β€’β€’β€’β€’
Online medical product store
libertymedical.comFort Pierce, United States1989Dec 2012β€’β€’β€’β€’
Medical applications are developed for healthcare by MedApps.
medapps.net2006Aug 2012β€’β€’β€’β€’
Automated drug screening services are provided for employers and clinics.
escreen.comOverland Park, United States1998Feb 2012$270M
Provider of a platform for health information exchange and EHR services
wellogic.comWaltham, United States1992Dec 2011β€’β€’β€’β€’
Golf course access and clubhouse facilities are offered to players.
arrivamedical.comOrlando, United States2008Sep 2010$65M
Develops point-of-care PCR assays for infectious diseases
ionian-tech.comSan Diego, United States2000Jul 2010β€’β€’β€’β€’
Personalized coaching is offered for employee healthy lifestyle behaviors.
alerewellbeing.comSeattle, United States2003β€’β€’β€’β€’
Premium access

Complete acquisition details for Alere

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Alere

16 dated milestones of Alere across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded Alere is founded.
  2. Funding First funding round.
  3. Exit Acquired by TA.
  4. Acquisition Acquires Ionian Technologies.
  5. Acquisition Acquires Arriva Medical.
  6. Acquisition Acquires Wellogic.
  7. Acquisition Acquires eScreen.
  8. Acquisition Acquires MedApps.
  9. Acquisition Acquires MedApps.
  10. Acquisition Acquires Liberty Medical.
  11. Acquisition Acquires NationsHealth.
  12. Acquisition Acquires Standard Diagnostic.
  13. Funding Latest funding round, Debt – Conventional, of $425.0M.
  14. Acquisition Acquires Biosite.
  15. Exit Acquired by Abbott.
  16. IPO Lists on the stock exchange (IPO).

Competitors of Alere

Alere has 2 listed competitors in our database, 1 of them funded. They include Nuna and Apollo Intelligence.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
nuna.com2010San Francisco, United States$90M161
Nuna is focused on AI-powered chronic disease management solutions.
apollointelligence.net2019Watertown, United States120
Data-driven decision-making solutions for healthcare organizations are provided.
Premium access

Detailed competitors of Alere

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Alere

Websites that share an audience with Alere (alere.com).

Similar websites

Websites whose visitors overlap most with Alere. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
fitsense.com.au
fitsense.com.au
100%
–
medibank.com.au
100%
1.2M#36,964View details
caresource.com
100%
1M#39,861View details
webmdhealthservices.com
100%
#1,079,747View details
alcon.com
100%
171K#286,128View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 18 similar websites and full traffic analytics for Alere

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 18 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Alere (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Alere

Premium access

Complete news archive for Alere

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alere

Alere was founded in 1991 and raised its 1st funding round 9 years after it was founded.

Alere is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.

Alere is a funded company, having raised a total of $616.22M across 26 funding rounds to date. The company's 1st funding round was a Series D of $150M, raised on Jun 2000.

Alere has 7,011 employees.

Founded in 1991 and headquartered in Waltham, United States, Alere operates in the diagnostics sector. Small rapid diagnostic devices are developed for infectious diseases, with additional focus on cardiology, oncology, drugs of abuse, and womens health. Products and services include over-the-counter tests, lab-based diagnostics, and integrated home monitoring solutions, serving various health management needs globally.

Alere's top competitors include Apollo Intelligence and Nuna.

Alere offers i-STAT, Afinion 2, and Cholestech LDX Analyzer.

Alere has made 11 acquisitions, including Alere Wellbeing, Arriva Medical, and Biosite.

Alere has 14 investors. Key investors include Abbott, UBS, Merrill Lynch, Gates Foundation, and Flagship Pioneering.

Alere operates through Alere Inc..

Yes. Alere was acquired by Abbott in February 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available